SARS‐CoV‐2, COVID‐19, skin and immunology – What do we know so far?

The pandemic condition coronavirus disease (COVID‐19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), can take asymptomatic, mild, moderate, and severe courses. COVID‐19 affects primarily the respiratory airways leading to dry cough, fever, myalgia, headache, fatig...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Allergy
Egile Nagusiak: Novak, Natalijia, Peng, Wenming, Naegeli, Mirjam C., Galvan, Christina, Kolm‐Djamei, Isabel, Brüggen, Charlotte, Cabanillas, Beatriz, Schmid‐Grendelmeier, Peter, Catala, Alba
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Review Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7404682/
https://ncbi.nlm.nih.gov/pubmed/32658359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.14498
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak